AstraZeneca Pharma

Astrazeneca admits its Covishield vaccine can cause a rare side effect: Learn more about this condition.

COVID 19
Latest News
Spotlight

DCGI Gives Nod To AstraZeneca Pharma India To Import, Market Selumetinib Capsules

September 27, 2021 16:00
Healthwire Bureau

Drug firm AstraZeneca Pharma India has received import and market permission from the Indian drug regulator for Selumetinib capsules. AstraZeneca Pharma India said in a regulatory filing, the company has…

View Post

Input your search keywords and press Enter.

Menu

AstraZeneca Pharma

AstraZeneca Admits Rare Side Effect Risk In Covishield Vaccine, Sparks Public Concern

DCGI Gives Nod To AstraZeneca Pharma India To Import, Market Selumetinib Capsules

Chilli Peppers May Potentially Fight Mesothelioma Cancer-Cells: Study Reveals

No MBBS Admissions Without Annual Declaration: NMC’s New Directive

High Court Slams Doctors for Prioritizing Private Practice Over Public Healthcare

National Cancer Awareness Day 2024: Fatigue, Unexplained Weight Loss, 6 Early Warning Signs of Cancer

Delhi AQI Today: Does Inhaling Toxic Smog Increases Heart Attack Risk?

Hearing Loss Is an Independent Risk Factor for Parkinson’s Disease: Jama Study Reveals

Breastfeeding Linked to Lower Rates of Postpartum Depression: Study Finds

Consuming High Levels of Omega-3, Omega-6 May Keep Cancer at Bay: Study Reveals